External Ventricular Drain (EVD) for Hydrocephalus
Treatment for Intracerebral Hemorrhage
Typical Dosage: CSF drainage, specific settings per ICP
Effectiveness
88%
Safety Score
50%
Clinical Trials
1
Participants
5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
CSF drainage, specific settings per ICP
Time to Effect
Immediate
Treatment Duration
Days to weeks
Evidence Quality
MODERATENumber Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$20,000
Side Effect Mgmt:$2,000
Total Annual:$22,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$20,000/QALY
QALYs Gained
1.2
Outcome-Based Costs
Cost per Responder
$24,444
External Ventricular Drain (EVD) for Hydrocephalus Outcomes
for Intracerebral Hemorrhage
Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+90%
Common Side Effects
Ventriculitis/Meningitis
+10%
Hemorrhage (catheter insertion)
+3%
Catheter occlusion
+2%
Active Clinical Trials
1 active trial recruiting for External Ventricular Drain (EVD) for Hydrocephalus in Intracerebral Hemorrhage
Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?
NCT05001750RECRUITINGPHASE1
84 participants
INTERVENTIONAL
The Bronx, United States
Started: Jun 14, 2021